Keratins and skin disorders

Journal of Pathology

Volumn 204, Issue 4, 2004, Pages 355-366

  Lane, E B ^a   McLean, W H I ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bullous congenital ichthyosiform erythroderma; Epidermolysis bullosa simplex; Genodermatoses; K5 K14; Keratin intermediate filaments; Pachyonychia congenita

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN; KERATIN; STRUCTURAL PROTEIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; CONGENITAL PACHYONYCHIA; CORNEA DYSTROPHY; CYTOSKELETON; DISEASE ASSOCIATION; EPIDERMOLYSIS BULLOSA SIMPLEX; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTERMEDIATE FILAMENT; KERATINOCYTE; KERATOSIS PALMOPLANTARIS; MONILETHRIX; NEVUS; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SKIN DISEASE;

CORNEAL DYSTROPHIES, HEREDITARY; CYTOSKELETON; EPIDERMOLYSIS BULLOSA SIMPLEX; HAIR; HUMANS; HYPERKERATOSIS, EPIDERMOLYTIC; ICHTHYOSIS; KERATINOCYTES; KERATINS; KERATODERMA, PALMOPLANTAR; MUTATION; NEVUS; PHENOTYPE; SKIN DISEASES;

EID: 7944238356     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1643     Document Type: Review

References (93)

1. Bonifas JM, Rothman AL, Epstein EH Jr. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991; 254: 1202-1205.
2. Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 1991; 66 1301-1311.
3. Lane EB, Rugg EL, Navsaria H, et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992; 356: 244-246.
4. Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999; 140: 815-828.
5. Horn HM, Tidman MJ. The clinical spectrum of epidermolysis bullosa simplex. Br J Dermatol 2000; 142: 468-472.
6. Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 2003; 19: 278-285.
7. Winter H, Schissel D, Parry DA, et al. An unusual Ala12Thr polymorphism in the 1A alpha-helical segment of the companion layer-specific keratin K6hf: evidence for a risk factor in the etiology of the common hair disorder pseudofolliculitis barbae. J Invest Dermatol 2004; 122: 652-657.
8. Mao JR, Bristow J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest 2001; 107: 1063-1069.
9. Roughley PJ, Rauch F, Glorieux FH. Osteogenesis imperfecta - clinical and molecular diversity. Eur Cell Mater 2003; 5: 41-47; discussion 47.
10. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve 2000; 23: 1456-1471.
11. Weber K, Geisler N. Intermediate filaments: structural conservation and divergence. Ann N Y Acad Sci 1985; 455: 126-143.
12. McLean WH, Lane EB. Intermediate filaments in disease. Curr Opin Cell Biol 1995; 7: 118-125.
13. Lane EB. Keratin diseases. Curr Opin Genet Dev 1994; 4: 412-418.
14. Covello SP, Smith FJ, Sillevis Smitt JH, et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139: 475-480.
15. Quinlan R, Hutchison C, Lane B. Intermediate filament proteins. Protein Profile 1995; 2: 795-952.
16. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
17. Hesse M, Zimek A, Weber K, Magin TM. Comprehensive analysis of keratin gene clusters in humans and rodents. Eur J Cell Biol 2004; 83: 19-26.
18. Gatter KC, Abdulaziz Z, Beverley P, et al. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 1982; 35: 1253-1267.
19. Coakham HB, Garson JA, Allan PM, et al. Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Pathol 1985; 38: 165-173.
20. Osborn M, Altmannsberger M, Debus E, Weber K. Differentiation of the major human tumor groups using conventional and monoclonal antibodies specific for individual intermediate filament proteins. Ann N Y Acad Sci 1985; 455: 649-668.
21. Steinert PM. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J Biol Chem 1990; 265: 8766-8774.
22. Lu X, Lane EB. Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: specific domain functions in keratin stabilization and filament formation. Cell 1990; 62: 681-696.
23. Owens DW, Lane EB. Keratin mutations and intestinal pathology. J Pathol 2004; 204: 377-385.
24. Porter RM, Lunny DP, Ogden PH, et al. K15 expression implies lateral differentiation within stratified epithelial basal cells. Lab Invest 2000; 80: 1701-1710.
25. Waseem A, Dogan B, Tidman N, et al. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol 1999; 112: 362-369.
26. Bosch FX, Leube RE, Achtstatter T, Moll R, Franke WW. Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ. J Cell Biol 1988; 106: 1635-4168.
27. Swensson O, Langbein L, McMillan JR, et al. Specialized keratin expression pattern in human ridged skin as an adaptation to high physical stress. Br J Dermatol 1998; 139: 767-775.
28. Stasiak PC, Purkis PE, Leigh IM, Lane EB. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92 707-716.
29. Anton-Lamprecht I, Schnyder UW. Epidermolysis bullosa herpetiformis Dowling-Meara. Report of a case and pathomorphogenesis. Dermatologica 1982; 164: 221-235.
30. Ishida-Yamamoto A, McGrath JA, Chapman SJ, Leigh IM, Lane EB, Eady RA. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol 1991; 97: 959-968.
31. Letai A, Coulombe PA, McCormick MB, Yu QC, Hutton E, Fuchs E. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex. Proc Natl Acad Sci U S A 1993; 90: 3197-3201.
32. Armstrong DK, McKenna KE, Purkis PE, et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet 1999; 8: 143-148.
33. McLean WH, Pulkkinen L, Smith FJ, et al. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 1996; 10: 1724-1735.
34. Smith FJ, Eady RA, Leigh IM, et al. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nature Genet 1996; 13: 450-457.
35. Paramio JM, Casanova ML, Segrelles C, Mittnacht S, Lane EB, Jorcano JL. Modulation of cell proliferation by cytokeratins K10 and K16. Mol Cell Biol 1999; 19: 3086-3094.
36. McLean WH, Eady RA, Dopping-Hepenstal PJ, et al. Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol 1994; 102 24-30.
37. Rothnagel JA, Dominey AM, Dempsey LD, et al. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992; 257: 1128-1130.
38. Cheng J, Syder AJ, Yu QC, Letai A, Paller AS, Fuchs E. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 1992; 70 5): 811-819.
39. Chipev CC, Korge BP, Markova N, et al. A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992; 70: 821-828.
40. Kremer H, Lavrijsen AP, McLean WH, et al. An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1. J Invest Dermatol 1998; 111: 1224-1226.
41. Paramio JM, Jorcano JL. Assembly dynamics of epidermal keratins K1 and K10 in transfected cells. Exp Cell Res 1994; 215 319-331.
42. Kartasova T, Roop DR, Holbrook KA, Yuspa SH. Mouse differentiation-specific keratins 1 and 10 require a pre-existing keratin scaffold to form a filament network. J Cell Biol 1993; 120: 1251-1261.
43. Collin C, Moll R, Kubicka S, Ouhayoun JP, Franke WW. Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res 1992; 202: 132-141.
44. Kremer H, Zeeuwen P, McLean WH, et al. Ichthyosis bullosa of Siemens is caused by mutations in the keratin 2e gene. J Invest Dermatol 1994; 103: 286-289.
45. McLean WH, Morley SM, Lane EB, et al. Ichthyosis bullosa of Siemens - a disease involving keratin 2e. J Invest Dermatol 1994; 103: 277-281.
46. Rothnagel JA, Traupe H, Wojcik S, et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nature Genet 1994; 7: 485-490.
47. Smith FJ, Maingi C, Covello SP, et al. Genomic organization and fine mapping of the keratin 2e gene (KRT2E): K2e V1 domain polymorphism and novel mutations in ichthyosis bullosa of Siemens. J Invest Dermatol 1998; 111: 817-821.
48. Moll I, Heid H, Franke WW, Moll R. Distribution of a special subset of keratinocytes characterized by the expression of cytokeratin 9 in adult and fetal human epidermis of various body sites. Differentiation 1987; 33: 254-265.
49. Reis A, Hennies HC, Langbein L, et al. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nature Genet 1994; 6: 174-179.
50. Navsaria HA, Swensson O, Ratnavel RC, et al. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995; 104: 425-429.
51. Covello SP, Irvine AD, McKenna KE, et al. Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland. J Invest Dermatol 1998; 111 1207-1209.
52. McGowan KM, Coulombe PA. Keratin 17 expression in the hard epithelial context of the hair and nail, and its relevance for the pachyonychia congenita phenotype. J Invest Dermatol 2000; 114 1101-1107.
53. De Berker D, Wojnarowska F, Sviland L, Westgate GE, Dawber RP, Leigh IM. Keratin expression in the normal nail unit: markers of regional differentiation. Br J Dermatol 2000; 142: 89-96.
54. McLean WH, Rugg EL, Lunny DP, et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nature Genet 1995; 9: 273-278.
55. Terrinoni A, Smith FJ, Didona B, et al. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. J Invest Dermatol 2001; 117: 1391-1396.
56. Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nature Genet 1995; 10: 363-365.
57. Smith FJ, Jonkman MF, van Goor H, et al. A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet 1998; 7: 1143-1148.
58. Smith FJ, Corden LD, Rugg EL, et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997; 108 220-223.
59. Irvine AD, Corden LD, Swensson O, et al. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nature Genet 1997; 16: 184-187.
60. Nishida K, Honma Y, Dota A, et al. Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am J Hum Genet 1997; 61: 1268-1275.
61. Corden LD, Swensson O, Swensson B, et al. Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel mutations in keratin 12 (K12) and complete sequence of the human KRT12 gene. Exp Eye Res 2000; 70: 41-49.
62. Rugg EL, McLean WH, Allison WE, et al. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nature Genet 1995; 11: 450-452.
63. Rugg E, Magee G, Wilson N, Brandrup F, Hamburger J, Lane E. Identification of two novel mutations in keratin 13 as the cause of white sponge naevus. Oral Dis 1999; 5: 321-324.
64. Richard G, De Laurenzi V, Didona B, Bale SJ, Compton JG. Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nature Genet 1995; 11: 453-455.
65. Langbein L, Rogers MA, Winter H, Praetzel S, Schweizer J. The catalog of human hair keratins. II. Expression of the six type II members in the hair follicle and the combined catalog of human type I and II keratins. J Biol Chem 2001; 276: 35 123-35 132.
66. Langbein L, Rogers MA, Winter H, et al. The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. J Biol Chem 1999; 274: 19 874-19 884.
67. Winter H, Clark RD, Tarras-Wahlberg C, Rogers MA, Schweizer J. Monilethrix: a novel mutation (Glu402Lys) in the helix termination motif and the first causative mutation (Asn114Asp) in the helix initiation motif of the type II hair keratin hHb6. J Invest Dermatol 1999; 113: 263-266.
68. Winter H, Vabres P, Larregue M, Rogers MA, Schweizer J. A novel missense mutation, A118E, in the helix initiation motif of the type II hair cortex keratin hHb6, causing monilethrix. Hum Hered 2000; 50: 322-324.
69. Winter H, Rogers MA, Gebhardt M, et al. A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. Hum Genet 1997; 101: 165-169.
70. Lane EB, Wilson CA, Hughes BR, Leigh IM. Stem cells in hair follicles. Cytoskeletal studies. Ann N Y Acad Sci 1991; 642: 197-213.
71. Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 1995; 104: 910-915.
72. Steinert PM, Yang JM, Bale SJ, Compton JG. Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem Biophys Res Commun 1993; 197: 840-848.
73. Chan YM, Yu QC, Fine JD, Fuchs E. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc Natl Acad Sci U S A 1993; 90: 7414-7418.
74. Rugg EL, Morley SM, Smith FJ, et al. Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function. Nature Genet 1993; 5: 294-300.
75. Irvine AD, McKenna KE, Jenkinson H, Hughes AE. A mutation in the V1 domain of keratin 5 causes epidermolysis bullosa simplex with mottled pigmentation. J Invest Dermatol 1997; 108: 809-810.
76. Uttam J, Hutton E, Coulombe PA, et al. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci U S A 1996; 93: 9079-9084.
77. Hatsell SJ, Eady RA, Wennerstrand L, et al. Novel splice site mutation in keratin 1 underlies mild epidermolytic palmoplantar keratoderma in three kindreds. J Invest Dermatol 2001; 116: 606-609.
78. Terron-Kwiatkowski A, Paller AS, Compton J, Atherton DJ, McLean WH, Irvine AD. Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J Invest Dermatol 2002; 119: 966-971.
79. Whittock NV, Smith FJ, Wan H, et al. Frameshift mutation in the V2 domain of human keratin 1 results in striate palmoplantar keratoderma. J Invest Dermatol 2002; 118: 838-844.
80. Sprecher E, Ishida-Yamamoto A, Becker OM, et al. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001; 116: 511-519.
81. Sybert VP, Francis JS, Corden LD, et al. Cyclic ichthyosis with epidermolytic hyperkeratosis: a phenotype conferred by mutations in the 2B domain of keratin K1. Am J Hum Genet 1999; 64: 732-738.
82. Terron-Kwiatkowski A, Terrinoni A, Didona B, et al. Atypical epidermolytic palmoplantar keratoderma presentation associated with a mutation in the keratin 1 gene. Br J Dermatol 2004; 150 1096-1103.
83. Paller AS, Moore JA, Scher R. Pachyonychia congenita tarda. A late-onset form of pachyonychia congenita. Arch Dermatol 1991; 127: 701-703.
84. Connors JB, Rahil AK, Smith FJ, McLean WH, Milstone LM. Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16. Br J Dermatol 2001; 144: 1058-1062.
85. Xiao SX, Feng YG, Ren XR, et al. A novel mutation in the second half of the keratin 17 1A domain in a large pedigree with delayed-onset pachyonychia congenita type 2. J Invest Dermatol 2004; 122: 892-895.
86. Coleman CM, Hannush S, Covello SP, Smith FJ, Uitto J, McLean WH. A novel mutation in the helix termination motif of keratin K12 in a US family with Meesmann corneal dystrophy. Am J Ophthalmol 1999; 128: 687-691.
87. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994; 8: 2964-2973.
88. Baribault H, Price J, Miyai K, Oshima RG. Mid-gestational lethality in mice lacking keratin 8. Genes Dev 1993; 7: 1191-1202.
89. Yasukawa K, Sawamura D, McMillan JR, Nakamura H, Shimizu H. Dominant and recessive compound heterozygous mutations in epidermolysis bullosa simplex demonstrate the role of the stutter region in keratin intermediate filament assembly. J Biol Chem 2002; 277: 23 670-23 674.
90. Hovnanian A, Pollack E, Hilal L, et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nature Genet 1993; 3: 327-332.
91. Koss-Harnes D, Hoyheim B, Anton-Lamprecht I, et al. A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J Invest Dermatol 2002; 118: 87-93.
92. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 2119-2124.
93. McGrath JA, McMillan JR, Shemanko CS, et al. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nature Genet 1997; 17: 240-244.